Research Article
Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway
Figure 4
MDA-MB-231-derived EVs carrying miR-887-3p promoted BC cell drug resistance. MDA-MB-231-derived EV-treated BC cells were exposed to 0.5 μM doxorubicin, 2.5 μM cisplatin, and 0.5 μM fulvestrant, respectively. Then, CCK-8 assay (a), colony formation assay (b), and flow cytometry (c) were performed to assess effects of MDA-MB-231-derived EVs carrying miR-887-3p on BC cell drug resistance. Data are exhibited as the . One-way ANOVA and Tukey’s multiple comparison test were used to determine statistical significance. . Three independent experiments were performed. BC: breast cancer; miR: microRNA; RT-qPCR: reverse transcription quantitative polymerase chain reaction; CCK-8: cell counting kit-8; ANOVA: analysis of variance.
(a) |
(b) |
(c) |